Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Helena Peschelová"'
Autor:
Zankruti Dave, Olga Vondálová Blanářová, Štěpán Čada, Pavlína Janovská, Nikodém Zezula, Martin Běhal, Kateřina Hanáková, Sri Ranjani Ganji, Pavel Krejci, Kristína Gömöryová, Helena Peschelová, Michal Šmída, Zbyněk Zdráhal, Šárka Pavlová, Jana Kotašková, Šárka Pospíšilová, Vítězslav Bryja
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) are malignancies characterized by the dependence on B-cell receptor (BCR) signaling and by the high expression of ROR1, the cell surface receptor for Wnt-5a. Both, BCR and ROR1 are the
Externí odkaz:
https://doaj.org/article/f859b8e261ed419caa9d076a1db931a2
Autor:
Michal Šmída, Aneta Ledererová, Šárka Pospíšilová, Helena Peschelová, Veronika Kozlová, Adriana Ladungova, Tomáš Loja, Jiri Mayer, Veronika Mančíková, Jan Verner, František Folber
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundWhile achieving prolonged remissions in other B cell-derived malignancies, chimeric antigen receptor (CAR) T cells still underperform when injected into patients with chronic lymphocytic leukemia (CLL). We studied the influence of genetics
Autor:
O. Vondalova-Blanarova, K. Gmöryöva, Šárka Pavlová, S. Cada, Zbynek Zdrahal, Helena Peschelová, N. Zezula, Jana Kotašková, S. R. Ganjani, Pavlína Janovská, Zankruti Dave, Katerina Hanakova, Šárka Pospíšilová, Pavel Krejci, Michal Šmída, Martin Behal, Vítězslav Bryja
Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) are malignancies characterized by the dependence on B-cell receptor (BCR) signaling and by the high expression of the cell surface receptor ROR1. Both, BCR and ROR1 are therapeutic tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bf182e5ab77831fb45b47605c542dd8
https://doi.org/10.1101/2020.05.29.124156
https://doi.org/10.1101/2020.05.29.124156
Autor:
Veronika Mancikova, Helena Peschelova, Veronika Kozlova, Aneta Ledererova, Adriana Ladungova, Jan Verner, Tomas Loja, Sarka Pospisilova, Michal Smida, Lenka Dostalova, Martin Culen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Background Anti-CD19 chimeric antigen receptor T cells (CART-19) frequently induce remissions in hemato-oncological patients with recurred and/or refractory B-cell tumors. However, malignant cells sometimes escape the immunotherapeutic targeting by C
Externí odkaz:
https://doaj.org/article/6bcdb3d13e154c7d93d622142968214e
Autor:
Veronika Mancikova, Helena Peschelova, Veronika Kozlova, Aneta Ledererova, Adriana Ladungova, Jan Verner, Tomas Loja, Frantisek Folber, Jiri Mayer, Sarka Pospisilova, Michal Smida
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundWhile achieving prolonged remissions in other B cell-derived malignancies, chimeric antigen receptor (CAR) T cells still underperform when injected into patients with chronic lymphocytic leukemia (CLL). We studied the influence of genetics
Externí odkaz:
https://doaj.org/article/259c3cf68f02459a9b6f9eafc6fa6aa2
Autor:
Veronika Kozlova, Aneta Ledererova, Adriana Ladungova, Helena Peschelova, Pavlina Janovska, Aleksander Slusarczyk, Joanna Domagala, Pavel Kopcil, Viera Vakulova, Jan Oppelt, Vitezslav Bryja, Michael Doubek, Jiri Mayer, Sarka Pospisilova, Michal Smida
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229170 (2020)
Surface protein CD20 serves as the critical target of immunotherapy in various B-cell malignancies for decades, however its biological function and regulation remain largely elusive. Better understanding of CD20 function may help to design improved r
Externí odkaz:
https://doaj.org/article/06ed8283ce80438ba455bb21d30ede91